New model of multiple sclerosis correlates demyelination with evolution of cognitive and motor abilities

No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules, researchers at Paris Brain Institute, coordinated by Bernard Zalc, have developed a new model of the disease described in Brain.

Leave A Comment

Your email address will not be published. Required fields are marked *